Product Information
SILDENAFIL 25 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1220 per EA under NDC 75834027200. Its NADAC has been published 199 times since Dec 14, 2022.
FDA first approved this application on Aug 25, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834027200
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SILDENAFIL CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209302FDA Approved
8/25/2020
TE Code
AB
On Market Since
6/16/2021
Pharmacological Classes
Price Statistics
The NADAC for SILDENAFIL 25 MG TABLET has been published 199 times since Dec 14, 2022, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1220 per EA |
|---|---|
| All-time high | $0.2635 (Apr 12, 2023) |
| All-time low | $0.0812 (Nov 20, 2024) |
| 52-week high | $0.1220 |
| 52-week low | $0.1029 |
| Median price | $0.1163 |
| Average price | $0.1340 |
| Largest weekly change | +84.8% (Aug 21, 2024) |
| Weeks tracked | 199 |
| Tracking since | Dec 14, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SILDENAFIL CITRATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nivagen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SILDENAFIL CITRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILDENAFIL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SILDENAFIL 25 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1220 per EA (NDC 75834027200), effective Sep 30, 2026.
How has the price of SILDENAFIL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SILDENAFIL 25 MG TABLET has declined 21.1%. It has been tracked across 199 weekly CMS publications since Dec 14, 2022.
What are the highest and lowest recorded NADAC prices for SILDENAFIL 25 MG TABLET?
Since Dec 14, 2022, the NADAC for SILDENAFIL 25 MG TABLET has ranged from a low of $0.0812 (Nov 20, 2024) to a high of $0.2635 (Apr 12, 2023), with a median of $0.1163 per EA.
Are there cheaper alternatives to SILDENAFIL 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SILDENAFIL 25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SILDENAFIL 25 MG TABLET?
SILDENAFIL 25 MG TABLET (NDC 75834027200) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.